|
KIAA1033 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.123800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.026400E-02 |
| Normal-vs-Stage2 |
1.739870E-03 |
| Normal-vs-Stage3 |
1.975960E-02 |
| Normal-vs-Stage4 |
5.501200E-03 |
| Stage1-vs-Stage2 |
4.262300E-02 |
| Stage1-vs-Stage3 |
3.268800E-01 |
| Stage1-vs-Stage4 |
1.598620E-01 |
| Stage2-vs-Stage3 |
3.509600E-01 |
| Stage2-vs-Stage4 |
7.835200E-01 |
| Stage3-vs-Stage4 |
5.188600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.550200E-02 |
| Normal-vs-AfricanAmerican |
4.312800E-01 |
| Normal-vs-Asian |
1.039630E-01 |
| Caucasian-vs-AfricanAmerican |
4.154600E-01 |
| Caucasian-vs-Asian |
7.600400E-01 |
| AfricanAmerican-vs-Asian |
5.734400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.181560E-02 |
| Normal-vs-Female |
3.519500E-02 |
| Male-vs-Female |
6.082800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.662600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.099500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.375630E-02 |
| Normal-vs-Age(81-100Yrs) |
9.956300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.828230E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.860400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.315600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.940200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.326200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.036000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.770200E-01 |
| Classical-VS-Follicular |
2.373600E-01 |
| Classical-VS-Other |
9.021600E-01 |
| Classical-VS-Normal |
6.067600E-02 |
| Tall-VS-Follicular |
3.719200E-01 |
| Tall-VS-Other |
9.839000E-01 |
| Tall-VS-Normal |
3.113000E-01 |
| Follicular-VS-Other |
6.462000E-01 |
| Follicular-VS-Normal |
1.870090E-02 |
| Other-VS-Normal |
5.356000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.143440E-03 |
| Normal-vs-N1 |
5.031500E-02 |
| N0-vs-N1 |
4.088600E-01 |
|
|
